argenx SE 2023 Annual Report with Sustainability Disclosures
Company: argenx SE
Sector: Manufacturing
Country: Netherlands
Year: 2023
Type: Annual Report with Sustainability Disclosures
Pages: 396
The report describes argenx's transition to a commercial-stage biopharma company, with VYVGART and VYVGART SC generating $1.2 billion in global product net sales in 2023. It reports 1,148 employees at year-end and a nine-member Board with three female directors. The report includes NFRD and EU Taxonomy disclosures, concludes its activities are non-eligible under the EU Taxonomy, and says it is preparing for CSRD reporting for 2024. The Board explicitly assumes ESG oversight, while its audit and compliance committee assists with ESG reporting and climate-related risks.
Services
From bulk PDFs to structured indicators and machine-readable documents.